Á lódáil...
Targeted Agents for HER2-Positive Breast Cancer: Optimal Use in Older Patients
Her-2 gene is over expressed in 15-20 percent of all breast cancers. With the advent of Her-2 directed therapies, Her-2 overexpression is no longer considered an adverse prognostic factor. Despite significant improvements in clinical outcomes with use of trastuzumab, women over the age of 65 remain...
Na minha lista:
| Foilsithe in: | Drugs Aging |
|---|---|
| Main Authors: | , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
2015
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4991772/ https://ncbi.nlm.nih.gov/pubmed/26645293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-015-0326-1 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|